Haleon completes purchase of 33pc share in Chinese JV
Haleon announced on Tuesday that it has finalised the acquisition of an additional 33% equity stake in its Chinese joint venture, Tianjin TSKF Pharmaceutical Co (TSKF), from Tianjin Pharmaceutical Group and Tianjin Pharmaceutical Da Ren Tang Group Corporation.
Haleon
31 December 2024 12:30:02
Source: Sharecast
The FTSE 100 consumer goods giant first announced the transaction, valued at CNY 4.465bn (£0.5bn), in September.
It said the acquisition received shareholder approval from DRTG at an extraordinary general meeting in November, with all other necessary regulatory clearances subsequently secured.
Haleon said it expected the transaction to be accretive to earnings per share.
As part of the agreement, Haleon held an option to acquire the remaining 12% stake in TSKF, while DRTG retained the right to sell its remaining interest to Haleon.
At 1212 GMT, shares in Haleon were up 0.56% at 376.2p.
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Bank of Scotland is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
Important legal information
Bank of Scotland Share Dealing Service is operated by Halifax Share Dealing Limited. Halifax Share Dealing Limited. Registered in England and Wales No. 3195646. Registered Office: Trinity Road, Halifax, West Yorkshire HX1 2RG. Authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.
The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.
Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.
